glp 1 drugs depression Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? GLP-1 drugs linked to less
Description
The Center for Medicare and Medicaid Innovation (CMMI) will closely track the model's impact on cost, outcomes and adherence to determine whether it's working to improve health and lower costs, per the announcement
How GLP-1s Workand Why Theyre Not Actually New GLP-1s (glucagon-like peptide-1 receptor agonists) are medications that mimic a hormone naturally produced in your gut

Yes, pharmaceutical companies are developing additional dual and triple agonist medications

At the highest doses, retatrutide seems to promise more significant weight loss than existing GLP-1s on the market but as dosage increases, so does the risk of side effects, mostly mild-to-moderate gastrointestinal issues, although one case of pancreatitis occurred in a patient on the 12mg dose during the phase II trial
Q: Is there a deadline to file
